DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties

In Chronic Myeloid Leukemia (CML), standard treatment consists of modern tyrosine-kinase inhibitors (TKI). Nevertheless, there is evidence that immune responses against leukemia-associated antigens (LAA) may play an important role in disease control. Dendritic cell (DC)- based immunotherapy is able...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Flörcken, Anne, Kopp, Joachim, Kölsch, Uwe, Meisel, Christian, Dörken, Bernd, Pezzutto, Antonio, Westermann, Jörg
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963053/
https://ncbi.nlm.nih.gov/pubmed/26864050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1132965
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars